Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Renee, interesting, can't find any other info about this deal.
BGFV hostile takeover attempt in progress, tread carefully!
He doesn't bother with us plebs. Company is solid balance sheet is strong if you have the means. Answer is 19,380 total shares.
lol right back to where it was.
IDK ran up a bit before the legalized gambling news, probably just profit taking.
Thinking this is just like follow-through from the Black Panther/Avengers movies success, stuff is hot right now but who knows with this thing anymore.
NUGL stairmaster
EQLB nice little walkup here but is it coming to an end, hmm.
So Schneider Brothers, LTD. have been diluting NMUS after not paying for their shares? Wow that's pretty rough, at least it wasn't a failed trial though. So they lost half the year waiting for financing to come through so they could move along with trials and now they'll need to raise more money. Not good but in the long run I don't think it really hurts the company's potential aside from being temporary headaches and lost time.
Up 400% since its IPO a month ago, damn it's just petfood and a flashy ticker symbol!
Thanks Renee at one time it had potential! But it's been busted ever since Danny Hammett got railroaded out of the co. by the toxic financier CFO.
Not me, I was one of the ones warning investors about this company way back in May '13 but point taken, investors are not without blame here.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87468610http://investorshub.advfn.com/boards/read_msg.aspx?message_id=87468610
It's a big club and you and I ain't in it. The Carmichaels have teams of lawyers and are probably connected to the SEC. There are those who are untouchable in this country, Hillary Clinton comes to mind. I'm not saying they are even in the same ballpark as her but I imagine there are also some higher-ups protecting these people for whatever reason. Only reasonable explanation as they always skate. Maybe one day CNBC will do an "American Greed" episode on them but I'm not holding my breath- they'll never ever get caught for anything as they are experts at this game.
SWZNF nice little walkup here, Lord Rothschild buying FANG shares so I heard.
Stranger things have happened, I do think AGGX has IP which may be of value to another company with better financing and the inclination to move it through clinical trials. If not a buyout, the best way forward would be for management to buy a clean shell and do a reverse-merger where AGGX shareholders get shares of the new controlling entity.
Thanks kindly to integral and Janice for answering my questions below, great info to learn about Regulation S-X and Regulation S-K as it pertains to Form 10 filers.
If anybody is aware of a specific case of a Form 15 filer complying with Regulation S-X and Regulation S-K and returning to fully reporting status I'd love to hear about that company and what the circumstances were. I'm not referring to "regular" companies that slip to the pink sheets by negligence or whatever and then file a Form 10 to become fully reporting again- just specifically Form 15 filers doing this. Thanks again!
Okay so I asked DD. You are correct that the registration becomes effective automatically after 60 days, even for a form 15 filer. However keep in mind SEC will kindly inform AGGX that it is still subject to Regulation S-X, Regulation S-K of the Sarbanes-Oxley Act or risk immediate Section 12(j) revocation irrespective of their beginning to file periodic reports. It would be in the best interests of AGGX to withdraw the 10-12g before it becomes effective if the company knows it cannot comply with Regulation S-X and Regulation S-K. While there is no concrete rule that precludes AGGX from becoming fully reporting upon effectiveness, there is also no known precedent of a form 15 filer complying with these regulations- which is what I have always maintained.
Let's suppose a Form 15 filer files a 10-12g to register securities:
1) Is the 60-day notice of effectiveness automatic in this case? Wouldn't regulators have something to say about a form 15 filer committing malfeasance and then turning around and registering securities?
2) Assuming the notice of effectiveness goes through and the shares are registered, what is the likelihood that a form 15 filer could return to full compliance?
The belief is that if a form 15 filer files a form 10 registration statement that becomes effective, they are now automatically subject to reporting requirements. I don't believe this to be the case. Am I wrong?
Okay, e-ore let's bring this to DD board. These people will have the answer.
"Upon effectiveness" key words. Very unlikely. Now I remember how your original claim came up.
haha
Thanks for that, nice find. I misspoke that Form 15 filers can't register shares and raise cash. I've seen another company do it before (NTEK) but I had forgotten that they were allowed. It was more of an impulse reaction like: "Oh wow they are registering shares"?
But let's be clear here, this has nothing to do with coming under SEC compliance. AGGX can't ever become fully reporting. They will need to merge or be bought out if shareholders are to see any realized value here.
CFTC Approves Options Trading In Bitcoin
http://www.zerohedge.com/news/2017-07-08/cftc-approves-options-trading-bitcoin
Hey I'm not saying it's not possible for them to register shares and raise cash. I believe they can still do that so I misspoke in my first post. The company does have value in their IP I think anybody following the board can agree on that. As I see it a buyout or merger might be in the cards but as it stands now the shell will remain that, a non-reporting entity. Hey at least it saves them on filing fees.
Form 15 is a one way ticket to PINKDOM. If you could name a company you could prove me wrong. But you can't because there are none.
Ok can you name one? Believe what you will. I am only telling you what I believe to be true.
We will see how far it goes. It would certainly set a precedent as the SEC has NEVER let a form 15 filer back into compliance.
They are trying to register shares? They're a form 15 filer. Who is advising them I wonder, doubt SEC will allow it. Correct me if I'm wrong. Not bashing by the way, I think there is some potential here but it is fraught with risk.
They won't split this. The low float ensures people will overpay and allows the trust to sell bitcoins at a premium. They will never kill the golden goose.
Looks like you're up 50% on this call, nice work TWNK.
Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.
The gross proceeds to Therapix from this offering are expected to be $12,000,000, prior to deducting underwriting discounts, commissions and other offering expenses. Therapix has granted the underwriters a 45-day option to purchase up to an additional 300,000 ADSs to cover over-allotments, if any.
Therapix plans to use the net proceeds from the offering to advance the formulation and clinical development efforts for its two lead product candidates, including Phase II clinical trials, and for working capital and other general corporate purposes.
Therapix's ADSs are scheduled to begin trading on the NASDAQ Capital Market on March 22, 2017, under the symbol "TRPX". The offering is expected to close on or about March 27, 2017, subject to customary closing conditions.
Laidlaw & Company (UK) Ltd., is acting as the sole book running manager for the offering.
SQZZ all data is as of 03/21/2017
CASH 81.66%
GARMIN LTD 1.90%
GROUPON INC 1.61%
LAREDO PETROLEUM INC 1.25%
AEGEAN MARINE PETROLEUM N 1.03%
EBIX INC 1.00%
GENERAL ELECTRIC CO. 0.99%
LUMBER LIQUIDATORS HOLDIN 0.96%
SPRINT NEXTEL CORP. 0.95%
SANCHEZ ENERGY CORP 0.84%
SIRIUS XM HOLDINGS INC 0.81%
WHITING PETROLEUM CORP 0.77%
OCLARO INC 0.77%
CENTRAL EUROPEAN MEDIA EN 0.76%
MCEWEN MINING INC 0.72%
LENDINGTREE INC 0.59%
ORITANI FINANCIAL CORP 0.51%
CHESAPEAKE ENERGY CORP. 0.48%
DENBURY RESOURCES INC. 0.45%
TRANSOCEAN LTD. 0.44%
QUOTIENT TECHNOLOGY INC 0.44%
WEIGHT WATCHERS INTERNATI 0.42%
CALIFORNIA RESOURCES CORP 0.41%
LINDSAY CORP 0.26%
GEMP is now Gemphire Therapeutics Inc which IPOd in August '16, Gemplus International SA was merged with Axalto on June 2, 2006.
Wow you bought QCOR in the dollar range!? Congrats! Shrewd investment and great job at sticking to your guns that long! That's what longterm investing is all about and we should all be so lucky as to find such a gem. Now I can understand why you wouldn't want to sell MNK down here. Yeah I remember a couple of guys on the QCOR yahoo board back in the day talking about buying it under a buck before they acquired Achtar.
I like microcap pharma, although I usually don't dabble in bios under a $200 million dollar market cap, I do track a fair amount of development stage bios. Since earnings rarely effect these stocks it is often less likely to be blindsided holding them. Sure binaries can be dangerous though which is why
I like holding onto good companies with promising drug candidates in between binary events. Exciting times to be an investor in this sector.
Thanks, good takes. My main concern is that it is simply the wrong time to own it with the Trump administration laying down the law to drug companies. He has consistently said drug prices are too high and let's face it, Acthar is a poster child for big pharma greed. The double edged sword is that Marathon could receive a fast track designation for Synacthen with Trump's new FDA in power (should they decide to seek FDA approval). I agree it's nice to have the issues of Acthar's monopoly cleared up- pay the fine and be done with it, get the bad press off MNK ASAP. "Look! It wasn't us who were anti-competitive, it was those other guys before us but here's a hundred million dollars to make the problem disappear". Right now though Achtar is still growing 10% YOY, thinking eventually something has to give. It is tough to pull the trigger on this one though. Difficult stock to get a read on. I was buying QCOR in the 17s in 2012. Sold way too soon in the 30s. One of the biggest mistakes I ever made, now I'm just trying to determine if the risk is worth the reward.
Do you really think it is going lower or is that just wishful thinking? MNK is already trading well below what it was before the QCOR acquisition. Just curious since you've followed the ACHTAR stuff for years.
Snapchat IPO tomorrow. Shares priced at $17, above the projected range, in the biggest U.S. debut since Alibaba.
we all lol'd, ETII